Skip to main content
BMJ Open logoLink to BMJ Open
. 2022 Dec 1;12(12):e066934. doi: 10.1136/bmjopen-2022-066934

Prevalence and predictors of spontaneous preterm births in Nepal: findings from a prospective, population-based pregnancy cohort in rural Nepal–a secondary data analysis

Seema Subedi 1,2,, Elizabeth A Hazel 1, Diwakar Mohan 1, Scott Zeger 3, Luke C Mullany 1, James M Tielsch 4, Subarna K Khatry 2, Steven C LeClerq 1,2, Robert E Black 1, Joanne Katz 1
PMCID: PMC9716942  PMID: 36456014

Abstract

Objective

Preterm birth can have short-term and long-term complications for a child. Socioeconomic factors and pregnancy-related morbidities may be important to predict and prevent preterm births in low-resource settings. The objective of our study was to find prevalence and predictors of spontaneous preterm birth in rural Nepal.

Design

This is a secondary observational analysis of trial data (registration number NCT01177111).

Setting

Rural Sarlahi district, Nepal.

Participants

40 119 pregnant women enrolled from 9 September 2010 to 16 January 2017.

Outcome measures

The outcome variable is spontaneous preterm birth. Generalized Estimating Equations Poisson regression with robust variance was fitted to present effect estimates as risk ratios.

Result

The prevalence of spontaneous preterm birth was 14.5% (0.5% non-spontaneous). Characteristics not varying in pregnancy associated with increased risk of preterm birth were maternal age less than 18 years (adjusted risk ratio=1.13, 95% CI: 1.02 to 1.26); being Muslim (1.53, 1.16 to 2.01); first pregnancy (1.15, 1.04 to 1.28); multiple births (4.91, 4.20 to 5.75) and male child (1.10, 1.02 to 1.17). Those associated with decreased risk were maternal education >5 years (0.81, 0.73 to 0.90); maternal height ≥150 cm (0.89, 0.81 to 0.98) and being from wealthier families (0.83, 0.74 to 0.93). Pregnancy-related morbidities associated with increased risk of preterm birth were vaginal bleeding (1.53, 1.08 to 2.18); swelling (1.37, 1.17 to 1.60); high systolic blood pressure (BP) (1.47, 1.08 to 2.01) and high diastolic BP (1.41, 1.17 to 1.70) in the third trimester. Those associated with decreased risk were respiratory problem in the third trimester (0.86, 0.79 to 0.94); having poor appetite, nausea and vomiting in the second trimester (0.86, 0.80 to 0.92) and third trimester (0.86, 0.79 to 0.94); and higher weight gain from second to third trimester (0.89, 0.87 to 0.90).

Conclusion

The prevalence of preterm birth is high in rural Nepal. Interventions that increase maternal education may play a role. Monitoring morbidities during antenatal care to intervene to reduce them through an effective health system may help reduce preterm birth.

Keywords: obstetrics, public health, epidemiology


STRENGTHS AND LIMITATIONS OF THIS STUDY.

  • This is a large population-based study that allows for analysis of rare and common risk factors for a relatively rare outcome (preterm).

  • Previous studies on preterm birth in Nepal were hospital based, enrolled women during delivery and have explored only the women’s sociodemographic factors associated with preterm birth, whereas our study is population based, enrols women from earlier in pregnancy, follows them monthly, and has explored symptom and morbidity variables that change through pregnancy.

  • Gestational age at outcome has been measured using date of last menstrual period (LMP) as usually done in low/middle-income countries; however, as LMP was asked at enrolment that was generally early in pregnancy, there is less recall bias than LMP recalled at delivery or late in pregnancy.

  • Missing data for second trimester morbidities due to late enrolment of some women in pregnancy are a limitation, but comparison of sociodemographic characteristics suggests limited potential for biases due to this limitation.

Introduction

Preterm birth (PTB) is defined as a birth occurring before 37 completed gestational weeks or fewer than 259 days from a woman’s last menstrual period (LMP).1 In 2010, the global prevalence of PTB estimated in 92 countries was 11.1% (95% CI: 9.1% to 13.4%), ranging from about 5% in some European countries to 18% in some African countries.2 Sixty per cent of these PTBs occurred in sub-Saharan Africa and South Asia.2 Complications of PTB were the leading causes of under-5 mortality and accounted for approximately 17.7% of all under-5 mortality and 36.1% of neonatal mortality, according to the 2019 global estimates.3 Eighty-one per cent of the under-5 deaths from complications of PTB occurred in Asia and sub-Saharan African countries.4

PTBs can have short-term and long-term consequences. Short-term consequences comprise increased risks of neonatal respiratory conditions, sepsis, neurological conditions, feeding difficulties, and visual and hearing problems.5–7 As the child grows, long-term consequences include more hospital admissions, poorer neurodevelopment outcomes, difficulties in learning, as well as behavioural and socioemotional problems.8–10 At the family level, PTB can lead to significant economic and psychological difficulties, and at the national level, it leads to significant cost for the health system.11 12

In Nepal, under-5 mortality has dropped from 64 deaths to 39 deaths per 1000 live births (LBs) from 2001 to 2016.13–15 In the same period, neonatal mortality rate (NMR) has also steadily declined (from 39 to 21 per 1000 LBs).13–15 Being an important determinant of neonatal mortality, PTB has become a greater contributor to under-5 mortality over time.16 If we do not consider interventions to address PTBs, it would be difficult to achieve Nepal’s Sustainable Development Goal that aims to reduce the neonatal mortality to 12 per 1000 LBs and under-5 mortality to 28 per 1000 LBs by 2030.17

There are very few studies on the prevalence or risk factors for PTB in Nepal,18 19 and those that exist have limitations. First, those studies are hospital based. Women enrolled in hospitals during delivery may suffer from systematic recall bias, where women having a PTB might report differently from women with term births. Also, at the time of delivery, women might have recall issues in reporting their date of LMP. Most importantly, enrolling at facilities has a selection bias, where the PTBs delivered at home or on the way to facilities are missed, possibly leading to underestimation of the prevalence and a different distribution of risk factors. Second, previous studies have included deliveries taken from urban tertiary hospitals in Nepal. Around 80% of the Nepalese population resides in rural areas20 and does not have access to delivery services at tertiary centres. Moreover, in rural areas, only 47% of deliveries are assisted by skilled birth attendants.14 So, the findings from those studies may not be representative of rural Nepal. Third, since the women’s enrolment was during delivery, they looked at only risk factors that did not vary in pregnancy and did not analyse changing symptoms, behaviours and maternal weight gain throughout pregnancy. Some of these symptoms may be indicative of conditions that can be addressed by antenatal care (ANC). The objective of our study was to estimate the prevalence and identify predictors/risk factors of spontaneous PTBs in rural Nepal. Understanding and addressing such risk factors are critical to addressing neonatal and child mortality and morbidity, particularly in resource-poor settings like Nepal.

Methods

Study design

This is a secondary data analysis with data taken from the Nepal Oil Massage Study (NOMS), which is a cluster-randomised community-based trial (ClinicalTrials.gov, NCT01177111) on the impact of sunflower seed oil versus standard of care mustard seed oil for neonatal massage on neonatal mortality and morbidity in rural Sarlahi district of Nepal. This study began by identifying married women of childbearing age (15–40 years) who consented to pregnancy surveillance. This involved following them every 5 weeks to see whether they became pregnant, based on a positive pregnancy test offered by the study team if a woman reported missing a period. If pregnant, they were consented and enrolled in the trial. During enrolment, demographic data, socioeconomic status, reproductive history and date of last menstruation were collected. One hundred twenty-three women (0.3%) refused to be followed after enrolment. Those who consented were visited monthly by a field worker until the pregnancy outcome occurred or the study ended. During these monthly visits, field workers asked some basic questions about signs and symptoms of morbidity during the previous 30-day period. At these visits, women also had their weight and blood pressure (BP)/pulse measured, and body temperature recorded. Women reporting signs of morbidity and indicating that these signs were currently present were referred to the local health post or primary health centre. Women with fever or elevated BP as measured by study staff were similarly referred for care but continued to be included in the study.

As soon as possible after labour began or the baby was delivered, family members or neighbours notified the local female study worker of the birth. She notified a specially trained team who visited the mother and infant as soon after birth as possible. They measured infant weight and time of weight measurement after birth, determined sex of the newborn and whether the baby was a singleton or multiple births.

Setting and participants

The study cohort consists of 40 119 pregnancies among married women of childbearing age, living in 34 Village Development Committees of Sarlahi district, enrolled from 9 September 2010 to 16 January 2017, in the NOMS. Pregnancies were followed monthly until delivery. LBs were categorised as term or preterm. Pregnancies ending in miscarriage, abortion and stillbirths (SBs) were excluded from the analysis. SBs were not included because the aetiology of these may be quite different from those of PTBs.

Variables

Outcome variable

The main outcome variable is spontaneous PTB among pregnancies that produced at least one live born infant, defined as pregnancies ending less than 259 gestational days from the first day of LMP date. LBs were based on women’s self- report. They were asked if the baby moved, cried or breathed after birth. If they said ‘yes’ to one or more of these, the birth was recorded as an LB. For gestational age (GA), women were asked about their LMP during enrolment, and the GA at outcome was calculated as the difference between reported LMP and the date of the child’s birth. PTBs were classified as spontaneous or non-spontaneous (caesarean section or/and induction), and only spontaneous PTBs were included in the regression analysis.

Independent variables

Through literature review and expert opinion, certain factors were included in the analysis of predictors.21 These can be categorised into pregnancy non-varying and pregnancy-varying variables. Pregnancy non-varying variables included sociodemographic, pregnancy history, current pregnancy and child-related variables that do not change during pregnancy. Pregnancy-varying variables included signs and symptoms of morbidity in pregnancy and maternal weight.

Sociodemographic variables like maternal age at LMP, caste/religion, maternal education, wealth quintile and maternal height were explored. Maternal age was categorised as less than 18, 18–35 and more than 35 years to assess the association of very young women and older women with PTBs. Caste/religion of the mothers (Brahmin/Chhetri, Vaishya, Shudra, Muslim and others) was used as per the caste category system in Nepal.22 Maternal education (no schooling, 1–5 years and more than 5 years) and maternal height (<145 cm, 145–<150 and ≥150) were used. Household wealth status was measured in quintiles based on a standardised score using principal component analysis of household assets.23

Prior pregnancy-related variables like parity (one to four, more than four, prior pregnancy but not resulting in LB or SB and no prior pregnancy); interpregnancy interval (IPI) defined as the time since the end of last pregnancy to the date of LMP of the current pregnancy, regardless of the outcome (<18, 18–36 and >36 months); any prior live born child who died (no prior LB died and died); any prior pregnancy that ended in an SB (no prior SB and SB); any prior pregnancy ending in miscarriage (no prior miscarriage and miscarriage); and any prior pregnancy that ended in multiple births (no prior multiple births and multiple births) were assessed.

Current pregnancy-related variables like tobacco intake (ever used any tobacco products during this pregnancy—yes and no) and alcohol intake (ever used alcohol during this pregnancy—yes and no) were assessed. Child-level variables like multiple births (singleton and twin/triplet) and sex of the child (male and female) were included. We used the category with the low risk according to literature of similar settings, to be the reference group if there was no clear hierarchy of risk (such as maternal age, caste) but selected the most at risk group for those where a hierarchy existed (such as maternal education, wealth quintile, maternal height).

Current pregnancy-related variables like tobacco and alcohol intake were not included in the regressions because rates of use were very low. Only 0.3% consumed alcohol and only 1.1% used tobacco. Other current pregnancy-related variables like number of ANC visits and place of delivery were shown in descriptive, but omitted from inferential analysis because in this setting, women with spontaneous PTBs could have missed the fourth ANC visit in the ninth month and preterm birth could be the cause of a lower number of visits. For place of delivery, spontaneous PTBs were more likely to be delivered at home or on the way to the facility, because many births in this environment are not planned to occur in a facility. However, we also included these variables in the multivariable regressions and provided these as supplemental analyses because ANC may be important in reducing PTB.

Symptoms of morbidity during pregnancy such as sexually transmitted infections (STIs), respiratory illness, gastrointestinal (GI) illness, poor appetite, nausea and vomiting, vaginal bleeding, swelling of hands or face, high systolic and diastolic BP were assessed. All these variables were assessed in the second and third trimesters, and so labelled as: problem in at least one visit of the second trimester—yes or no, and problem in at least one visit in the third trimester—yes or no. We did not include symptoms of morbidities in the first trimester because only 41% women were enrolled in the first trimester, and so 59% missed symptom information in the first trimester. Maternal weight gain was defined as the average weight in the third trimester minus the average weight in the second trimester. For measurement of these symptom variables, field workers asked if women had symptoms of morbidity at any time in the past 30 days, at each monthly visit during pregnancy. STI was defined as painful or burning urination, or foul-smelling vaginal discharge. Respiratory illness was defined as persistent cough, or difficult or rapid breathing, or wheezing/grunting, or shortness of breath. GI illness was defined as watery stools (four or more times in a day or blood or white mucus in the stool). Appetite-related illness was defined as poor appetite, nausea or vomiting. Vaginal bleeding was defined as spots of blood from the vagina. Swelling was defined as swelling of hands and/or face. Foot/leg swelling was excluded since it is common during pregnancy and not indicative of underlying disease. BP measurements were categorised as high systolic BP if the systolic measurement was ≥140 mm Hg, and high diastolic BP if diastolic measurement was ≥90 mm Hg at any monthly visit within the second or third trimester.

Statistical methods

First, a descriptive analysis was done to show the frequencies of pregnancy non-varying variables (sociodemographic, prior pregnancy related, current pregnancy and child related) and pregnancy-varying variables (symptoms and maternal weight) by spontaneous preterm and term births. Second, bivariable Generalized Estimating Equations (GEE) Poisson regression with robust variance was used to examine associations between each risk factor and the outcome to get an unadjusted risk ratio. Since the prevalence of our outcome was more than 10%, we used Poisson regression with robust variance because we wanted to report associations as risk ratios. Third, multivariable GEE Poisson regression with robust variance was used including variables that were significant in the bivariable models, to get the adjusted risk ratios (ARRs). GEE was used because in the study, 52% of women had multiple pregnancies. Since our unit of analysis is pregnancy and pregnancies were nested within women, women’s ID variable was used as cluster for GEE modelling.

We included a larger number of potential risk factors to provide a general description of the study population but did not include all of these in the regression analysis. Some variables were highly correlated with each other (such as some reproductive history variables) and we chose just to include one rather than all, and for others, the prevalence was so low that we did not think helpful to include in the regression (for example, smoking and alcohol use). Some of the variables in the unadjusted analysis were not included in the regression because they were not statistically significant in the unadjusted analysis. For example, prior pregnancy ending in miscarriage, SB or prior multiple births were not included (as these were highly correlated with each other and not statistically significant in crude models). We did include death of a prior LB, which was significant in the crude model.

The descriptive analysis had 31 851 pregnancies. In the regression analysis, we excluded the 1093 pregnancies (3.4%) that ended in caesarean section, induction or both, which leaves 30 758 for analysis. Then, 30.7% out of 30 758 (20.2% missing morbidity in second trimester due to enrolment only in third trimester, 9.4% missing morbidity in third trimester and 1.1% missing other variables) were missing in the regression analysis, and so the final multivariable regression analysis excluded those 9461 pregnancies, and consisted of 21 297 pregnancies.

Patient and public involvement

Patients or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this study.

Results

Participants

The analytical population is 31 851 pregnancies that ended in at least one LB and had information on GA at outcome. The detailed flow chart is given in figure 1. Most women were enrolled in the first and second trimesters (41% each), followed by the third trimester (18%). Overall, the mean GA at enrolment was 18 weeks. For first, second and third trimesters, the mean GAs at enrolment were 9, 19 and 34 weeks, respectively. Fifty-two per cent of women (33% with two pregnancies, 14% with three pregnancies, 4% with four pregnancies and 1% with more than four pregnancies) contributed more than one pregnancy to the study.

Figure 1.

Figure 1

Flow diagram of participants. GA, gestational age; LB; live birth; LFUP, loss to follow-up; SB, stillbirth.

Descriptive analysis

For pregnancy non-varying variables, as seen in table 1, 15% of women were younger (less than 18 years) and 2% of women were older (more than 35 years of age). Nine per cent of women were Muslim caste/religion. Two-thirds of women did not go to school, whereas only nearly one-fourth had education of more than 5 years. Fifteen per cent of women had height <145 cm. About one-third (29%) of women had their first pregnancy in this study and 64% had one to four prior LBs or SBs. Among those who had a previous pregnancy, 6% had prior SB, 16% experienced miscarriage and 16% had an LB that died, and only 1% had prior multiple births. Half of the women had an IPI of less than 18 months, and 28% of women had four or more ANC visits. Half of the babies were born at home and 2% were born on the way to a facility or outdoors. Only 1.1% consumed tobacco and only 0.3% consumed alcohol during pregnancy. Half of the current pregnancies (51%) resulted in male children, and less than 1% resulted in multiple births. Only 3.4% of pregnancies underwent either caesarean section or induction or both.

Table 1.

Distribution of pregnancy non-varying variables by preterm and term births

Variables Categories Total Term Preterm
N=31 851 N=27 059 N=4792
N (%) N (%) N (%)
Maternal age at LMP 18–35 26 206 (82.3) 22 423 (82.9) 3783 (78.9)
Less than 18 4946 (15.5) 4100 (15.2) 846 (17.7)
More than 35 699 2.2) 536 2.0) 163 (3.4)
Caste/religion Brahmin and Chhetri 963 (3.0) 857 (3.2) 106 (2.2)
Vaishya 22 946 (72.0) 19 701 (72.8) 3245 (67.7)
Shudra 4922 (15.5) 4111 (15.2) 811 (16.9)
Muslim and others 2989 (9.4) 2365 (8.7) 624 (13.0)
Missing 31 (0.1) 25 (0.1) 6 (0.1)
Maternal education No schooling 21 427 (67.3) 17 915 (66.2) 3512 (73.3)
1–5 years 2713 (8.5) 2330 (8.6) 383 (8.0)
More than 5 years 7681 (24.1) 6786 (25.1) 895 (18.7)
Missing 30 (0.1) 28 (0.1) 2 (0.0)
Quintiles of wealth Poorest 6510 (20.4) 5340 (19.7) 1170 (24.4)
Poor 6380 (20.0) 5403 (20.0) 977 (20.4)
Middle 6320 (19.8) 5314 (19.6) 1006 (21.0)
Richer 6296 (19.8) 5470 (20.2) 826 (17.2)
Richest 6324 (19.9) 5516 (20.4) 808 (16.9)
Missing 21 (0.1) 16 (0.1) 5 (0.1)
Maternal height (cm) <145 4689 (14.7) 3885 (14.4) 800 (16.7)
145–<150 9559 (29.9) 8025 (29.7) 1527 (31.9)
≥150 17 581 (55.1) 15 111 (55.8) 2454 (51.2)
Missing 51 (0.2) 38 (0.14) 11 (0.2)
Parity including both LB and SB, at enrolment Parity 1–4 20 317 (63.8) 17 366 (64.2) 2951 (61.6)
More than 4 1383 (4.3) 1117 (4.1) 266 (5.6)
Prior pregnant but parity 0 787 (2.5) 672 (2.5) 115 (2.4)
No prior pregnancy 9195 (28.9) 7769 (28.7) 1426 (29.8)
Missing 169 (0.5) 135 (0.5) 34 (0.7)
Interpregnancy interval based on maternal recall 18–36 months 7927 (24.9) 6787 (25.1) 1140 (23.8)
Less than 18 months 11 461 (36.0) 9701 (35.9) 1760 (36.7)
More than 36 months 3256 (10.2) 2794 (10.3) 462 (9.6)
No prior pregnancy 9195 (28.9) 7769 (28.7) 1426 (29.8)
Missing 12 (0.0) 8 (0.0) 4 (0.1)
Any deaths among prior LB Prior LB but not died 17 488 (54.9) 14 999 (55.4) 2489 (51.9)
Prior LB died 3618 (11.4) 2999 (11.1) 619 (12.9)
Prior pregnancy but no LB 1073 (3.4) 909 (3.4) 164 (3.4)
No prior pregnancy 9195 (28.9) 7769 (28.7) 1426 (29.8)
Missing 477 (1.5) 383 (1.4) 94 (2.0)
Any prior pregnancy ended in SB Prior pregnancy but no SB 21 270 (66.8) 18 127 (67.0) 3143 (65.6)
Prior SB 1371 (4.3) 1150 (4.2) 221 (4.6)
No prior pregnancy 9195 (28.9) 7769 (28.7) 1426 (29.8)
Missing 15 (0.0) 13 (0.0) 2 (0.0)
Any prior pregnancy ended in miscarriage Prior pregnancy but no miscarriage 19 025 (59.7) 16 176 (59.8) 2849 (59.5)
Prior miscarriage 3621 (11.4) 3104 (11.5) 517 (10.8)
No prior pregnancy 9195 (28.9) 7769 (28.7) 1426 (29.8)
Missing 10 (0.0) 10 (0.0) 0 (0.0)
Any prior pregnancy ended in multiple births Prior pregnancy but no multiple births 22 343 (70.1) 19 030 (70.3) 3313 (69.1)
Prior multiple births 292 (0.9) 241 (0.9) 51 (1.1)
No prior pregnancy 9195 (28.9) 7769 (28.7) 1426 (29.8)
Missing 21 (0.1) 19 (0.1) 2 (0.0)
Number of ANC visits None 5520 (17.3) 4524 (16.7) 996 (20.8)
1 4146 (13.0) 3420 (12.6) 726 (15.2)
2–3 9779 (30.7) 8158 (30.1) 1621 (33.8)
4 or more 8909 (28.0) 8021 (29.6) 888 (18.5)
Missing 3497 (11.0) 2936 (10.9) 561 (11.7)
Place of delivery Home/Maiti 15 776 (49.5) 13 270 (49.0) 2506 (52.3)
HP/clinic/hospital 12 016 (37.7) 10 406 (38.5) 1610 (33.6)
Way to facility/outdoors 610 (1.9) 486 (1.8) 124 (2.6)
Missing 3449 (10.8) 2897 (10.7) 552 (11.5)
Bidi or tobacco use in pregnancy No 31 498 (98.9) 26 789 (99.0) 4709 (98.3)
Yes 353 (1.1) 270 (1.0) 83 (1.7)
Alcohol use (jaard or rakshi) in pregnancy? No 31 756 (99.7) 26 982 (99.7) 4774 (99.6)
Yes 95 (0.3) 77 (0.3) 18 (0.4)
Multiple births Singleton 31 587 (99.2) 26 946 (99.6) 4641 (96.8)
Twin/triplet 264 (0.8) 113 (0.4) 151 (3.2)
Sex of the child Female 15 182 (47.7) 13 063 (48.3) 2119 (44.2)
Male 16 306 (51.2) 13 794 (51.0) 2512 (52.4)
Twin/triplet 264 (0.8) 113 (0.4) 151 (3.2)
Missing 99 (0.3) 89 (0.3) 10 (0.2)
Induction or CS done Only induction 193 (0.6) 166 (0.6) 27 (0.6)
Only CS 868 (2.7) 735 (2.8) 133 (2.8)
Both induction and CS 32 (0.1) 28 (0.1) 4 (0.08)
None 30 758 (96.6) 26 130 (96.6) 4628 (96.6)

ANC, antenatal care; CS, caesarean section; HP, Health Post; LB, live birth; LMP, last menstrual period; SB, stillbirth.

For pregnancy-varying variables, as seen in table 2, poor appetite, nausea and vomiting was the most commonly reported symptom in both the second (39%) and third trimesters (20%); and vaginal bleeding was the least reported symptom (1.2% in the second and 0.6% in the third trimester). Very few women had high systolic BP (0.5% and 0.8%) and high diastolic BP (1.5% and 2.9%) in second and third trimesters, respectively. The average weight gained by women from second to third trimester was 3.5 kg.

Table 2.

Distribution of pregnancy-varying variables by preterm and term births

Variables Total Term Preterm
N=31 851 N=27 059 N=4792
N (%) N (%) N (%)
STI in at least one visit of 2nd trimester? No 20 823 (65.4) 17 497 (64.7) 3326 (69.4)
Yes 4593 (14.4) 3855 (14.2) 738 (15.4)
Missing 6435 (20.2) 5707 (21.1) 728 (15.2)
STI in at least one visit of 3rd trimester? No 25 931 (81.4) 22 512 (83.2) 3419 (71.3)
Yes 2963 (9.3) 2569 (9.5) 394 (8.2)
Missing 2957 (9.3) 1978 (7.3) 979 (20.4)
Respiratory problems in at least one visit of 2nd trimester? No 17 963 (56.4) 15 081 (55.7) 2882 (60.1)
Yes 7452 (23.4) 6271 (23.2) 1181 (24.6)
Missing 6436 (20.2) 5707 (21.1) 729 (15.2)
Respiratory problems in at least one visit of 3rd trimester? No 22 860 (71.8) 19 743 (73.0) 3117 (65.0)
Yes 6034 (18.9) 5338 (19.7) 696 (14.5)
Missing 2,957 (9.3) 1978 (7.3) 979 (20.4)
GI problems in at least one visit of 2nd trimester? No 22 742 (71.4) 19 136 (70.7) 3606 (75.3)
Yes 2673 (8.4) 2216 (8.2) 457 (9.5)
Missing 6436 (20.2) 5707 (21.1) 729 (15.2)
GI problems in at least one visit of 3rd trimester? No 26 152 (82.1) 22 712 (83.9) 3440 (71.8)
Yes 2742 (8.6) 2369 (8.8) 373 (7.8)
Missing 2957 (9.3) 1978 (7.3) 979 (20.4)
Poor appetite, nausea and vomiting in at least one visit of 2nd trimester? No 13 121 (41.2) 10 814 (40.0) 2307 (48.1)
Yes 12 295 (38.6) 10 538 (38.9) 1757 (36.7)
Missing 6435 (20.2) 5707 (21.1) 728 (15.2)
Poor appetite, nausea and vomiting in at least one visit of 3rd trimester? No 22 486 (70.6) 19 437 (71.8) 3049 (63.6)
Yes 6409 (20.1) 5645 (20.9) 764 (15.9)
Missing 2956 (9.3) 1977 (.3) 979 (20.4)
Vaginal bleeding in at least one visit of 2nd trimester? No 25 042 (78.6) 21 036 (77.7) 4006 (83.6)
Yes 373 (1.2) 315 (1.2) 58 (1.2)
Missing 6436 (20.2) 5708 (21.1) 728 (15.2)
Vaginal bleeding in at least one visit of 3rd trimester? No 28 716 (90.2) 24 938 (92.2) 3778 (78.8)
Yes 178 (0.6) 143 (0.5) 35 (0.7)
Missing 2957 (9.3) 1978 (7.3) 979 (20.4)
Swelling in at least one visit of 2nd trimester? No 24 846 (78.0) 20 904 (77.3) 3942 (82.3)
Yes 571 (1.8) 448 (1.7) 123 (2.6)
Missing 6434 (20.2) 5707 (21.1) 727 (15.2)
Swelling in at least one visit of 3rd trimester? No 27 754 (87.1) 24 126 (89.2) 3628 (75.7)
Yes 1141 (3.6) 956 (3.5) 185 (3.9)
Missing 2956 (9.3) 1977 (7.3) 979 (20.4)
High systolic BP in 2nd trimester? Normal systolic BP 25 260 (79.3) 21 217 (78.4) 4043 (84.4)
High systolic BP 158 (0.5) 136 (0.5) 22 (0.5)
Missing 6433 (20.2) 5706 (21.1) 727 (15.2)
High systolic BP in 3rd trimester? Normal systolic BP 28 659 (90.0) 24 905 (92.0) 3754 (78.3)
High systolic BP 241 (0.8) 181 (0.7) 60 (1.3)
Missing 2951 (9.3) 1973 (7.3) 978 (20.4)
High diastolic BP in 2nd trimester? Normal diastolic BP 24 945 (78.3) 20 976 (77.5) 3969 (82.8)
High diastolic BP 473 (1.5) 377 (1.4) 96 (2.0)
Missing 6433 (20.2) 5706 (21.1) 727 (15.2)
High diastolic BP in 3rd trimester? Normal diastolic BP 27 982 (87.9) 24 360 (90.0) 3622 (75.6)
High diastolic BP 918 (2.9) 726 (2.7) 192 (4.0)
Missing 2951 (9.3) 1973 (7.3) 978 (20.4)
Average weight in 3rd trimester minus average weight in 2nd trimester in kg (mean (SD)) 3.5 (2.1) 3.6 (2.1) 2.9 (2.2)

BP, blood pressure; GI, gastrointestinal; STI, sexually transmitted infection.

Outcome data

There were 4792 PTBs out of 31 851 pregnancies with at least one LB. Hence, the prevalence of PTB was 15% (95% CI: 14.6% to 15.4%) among the pregnancies enrolled between 9 September 2010 and 16 January 2017. Spontaneous PTB was 14.5% and non-spontaneous PTB was 0.5%. On looking at severity of spontaneous PTB, the prevalence were 0.5%, 1.4%, 2.1% and 10.5% for extreme PTB (<28 weeks), very PTB (28–<32 weeks), moderate PTB (32–<34 weeks) and late PTB (34–<37 weeks), respectively.

Main results

The main results are shown in table 3. Pregnancy non-varying variables that increased the risk of spontaneous PTB were maternal age less than 18 years (ARR=1.13, 95% CI: 1.02 to 1.26); being Muslim compared with Brahmin and Chhetri (1.53, 1.16 to 2.01); first pregnancy as compared with parity 1–4 (1.15, 1.04 to 1.28); having multiple births (4.91, 4.20 to 5.75) and having a male child (1.10, 1.02 to 1.17). Pregnancy non-varying variables that decreased the risk of spontaneous PTB were maternal education of more than 5 years (0.81, 0.73 to 0.90); maternal height of ≥150 cm (0.89, 0.81 to 0.98) and being wealthier: richer (0.83, 0.74 to 0.93) wealth quintile compared with the poorest wealth quintile. Pregnancy non-varying variables that showed no association with spontaneous PTBs in the bivariable/unadjusted models are any prior pregnancy ending in SB, any prior pregnancy ending in multiple births, any prior pregnancy ending in miscarriage and IPI. The pregnancy non-varying variable that showed an association in the bivariable model, but not in the multivariable models, was any prior pregnancy ending in death for an LB.

Table 3.

Crude and adjusted risk ratios for associations between risk factors and spontaneous preterm birth

Name of variables Categories Unadjusted model Adjusted model (N=21 297)
Risk ratio (95% CI) Risk ratio (95% CI)
Maternal age at LMP 18–35 1 1
Less than 18 1.19*** (1.11 to 1.28) 1.13* (1.02 to 1.26)
More than 35 1.57*** (1.36 to 1.81) 1.22 (0.98 to 1.51)
Caste/religion categories Brahmin and Chhetri 1 1
Vaishya 1.33** (1.09 to 1.62) 1.23 (0.95 to 1.59)
Shudra 1.55*** (1.26 to 1.90) 1.23 (0.94 to 1.62)
Muslim and others 1.96*** (1.60 to 2.42) 1.53** (1.16 to 2.01)
Mother’s years of education No schooling 1 1
1–5 years 0.86** (0.78 to 0.95) 0.91 (0.80 to 1.03)
More than 5 years 0.71*** (0.66 to 0.76) 0.81*** (0.73 to 0.90)
Quintiles of wealth Poorest 1 1
Poor 0.86*** (0.79 to 0.93) 0.90* (0.82 to 1.00)
Middle 0.89** (0.82 to 0.96) 0.95 (0.86 to 1.05)
Richer 0.73*** (0.67 to 0.79) 0.83** (0.74 to 0.93)
Richest 0.71*** (0.65 to 0.77) 0.88* (0.78 to 1.00)
Mother’s height (cm) <145 1 1
145–<150 0.93 (0.86 to 1.01) 0.98 (0.88 to 1.08)
≥150 0.81*** (0.75 to 0.87) 0.89* (0.81 to 0.98)
Parity including both LB and SB, at enrolment Parity 1–4 1 1
More than 4 1.32*** (1.17 to 1.48) 1.17 (0.99 to 1.37)
Prior pregnancy but parity 0 1.02 (0.85 to 1.22) 0.92 (0.62 to 1.37)
No prior pregnancy 1.10** (1.04 to 1.17) 1.15** (1.04 to 1.28)
Interpregnancy interval 18–36 months 1 1
Less than 18 months 1.07 (0.99 to 1.14) 1.08 (0.99 to 1.18)
More than 36 months 0.98 (0.89 to 1.09) 0.9 (0.79 to 1.02)
No prior pregnancy 1.11** (1.03 to 1.20) 1 (1.00 to 1.00)
Any death among prior LB Prior LB but not died 1 1
Prior LB died 1.19*** (1.09 to 1.29) 1.07 (0.97 to 1.19)
Prior pregnancy but no LB 1.07 (0.92 to 1.25) 1.06 (0.75 to 1.49)
No prior pregnancy 1.12*** (1.06 to 1.19) 1 (1.00 to 1.00)
Any prior pregnancy ended in SB Prior pregnancy but no SB 1
Prior SB 1.08 (0.94 to 1.23)
No prior pregnancy 1.08** (1.02 to 1.15)
Any prior pregnancy ended in miscarriage Prior pregnancy but no miscarriage 1
Prior miscarriage 0.94 (0.86 to 1.03)
No prior pregnancy 1.07* (1.01 to 1.13)
Any prior pregnancy ended in multiple births Prior pregnancy but no multiple births 1
Prior multiple births 1.14 (0.87 to 1.49)
No prior pregnancy 1.08** (1.02 to 1.14)
Multiple births Singleton 1 1
Twin/triplet 3.92*** (3.52 to 4.38) 4.91*** (4.20 to 5.75)
Sex of the child Female 1 1
Male 1.10*** (1.04 to 1.17) 1.10** (1.02 to 1.17)
Twin/triplet 4.13*** (3.69 to 4.63) 1
STI in at least one visit of 2nd trimester? No 1
Yes 0.99 (0.92 to 1.07)
STI in at least one visit of 3rd trimester? No 1
Yes 1.01 (0.92 to 1.12)
Respiratory problems in at least one visit of 2nd trimester? No 1 1
Yes 1 (0.94 to 1.06) 1.08 (1.00 to 1.16)
Respiratory problems in at least one visit of 3rd trimester? No 1 1
Yes 0.85*** (0.79 to 0.92) 0.86** (0.79 to 0.94)
GI problems in at least one visit of 2nd trimester? No 1
Yes 1.08 (0.98 to 1.18)
GI problems in at least one visit of 3rd trimester? No 1
Yes 1.04 (0.94 to 1.16)
Poor appetite, nausea and vomiting in at least one visit of 2nd trimester? No 1 1
Yes 0.81*** (0.77 to 0.86) 0.86*** (0.80 to 0.92)
Poor appetite, nausea and vomiting in at least one visit of 3rd trimester? No 1 1
Yes 0.88** (0.82 to 0.95) 0.86*** (0.79 to 0.94)
Vaginal bleeding in at least one visit of 2nd trimester? No 1 1
Yes 0.91 (0.71 to 1.17) 0.84 (0.71 to 1.17)
Vaginal bleeding in at least one visit of 3rd trimester? No 1 1
Yes 1.44* (1.05 to 1.98) 1.53* (1.08 to 2.18)
Swelling in at least one visit of 2nd trimester? No 1 1
Yes 1.32*** (1.12 to 1.55) 1.19 (0.98 to 1.46)
Swelling in at least one visit of 3rd trimester? No 1 1
Yes 1.25** (1.09 to 1.44) 1.37*** (1.17 to 1.60)
High systolic BP in 2nd trimester? Normal systolic BP 1 1
High systolic BP 0.89 (0.59 to 1.34) 0.67 (0.40 to 1.12)
High systolic BP in 3rd trimester? Normal systolic BP 1 1
High systolic BP 1.92*** (1.52 to 2.41) 1.47* (1.08 to 2.01)
High diastolic BP in 2nd trimester? Normal diastolic BP 1 1
High diastolic BP 1.34** (1.12 to 1.60) 1.09 (0.85 to 1.40)
High diastolic BP in 3rd trimester? Normal diastolic BP 1 1
High diastolic BP 1.57*** (1.37 to 1.80) 1.41*** (1.17 to 1.70)
Average weight in 3rd trimester minus average weight in 2nd trimester (kg) 0.88*** (0.87 to 0.90) 0.89*** (0.87 to 0.90)

*P<0.05, **p<0.01, ***p<0.001.

BP, blood pressure; GI, gastrointestinal; LB, live birth; LMP, last menstrual period; SB, stillbirth; STI, sexually transmitted infection.

For morbidity symptoms, some increased the risk of preterm, and all of these showed increased risk when symptoms were present in the third trimester. Having vaginal bleeding (ARR=1.53, 95% CI: 1.08 to 2.18); swelling (1.37, 1.17 to 1.60); high systolic BP (1.47, 1.08 to 2.01) and high diastolic BP (1.41, 1.17 to 1.70) in the third trimester significantly increased the risk of spontaneous PTB. Some symptom variables significantly decreased the risk of spontaneous PTB. Having respiratory problem in the third trimester (0.86, 0.79 to 0.94); and having poor appetite, nausea and vomiting in the second trimester (0.86, 0.80 to 0.92) and in the third trimester (0.86, 0.79 to 0.94) decreased the risk of spontaneous PTB. Symptom variables that showed no association with spontaneous PTB were STI and GI problems. Symptom variables that were significant in the bivariable model, but not significant in the multivariable models, were swelling in the second trimester and diastolic BP in the second trimester. For maternal weight, higher weight gain from the second to the third trimester was associated with a decreased risk of spontaneous PTB (0.89, 0.87 to 0.90).

To examine the possible bias associated with exclusion of pregnancies with missing data, we compared characteristics of women excluded in the regression analysis (n=9461) (mainly because of missing morbidity in second trimester due to late enrolment) with those included in the regression analysis (n=21 297) (online supplemental table 1). The women excluded in the regression analysis were slightly better off than those included in the regression based on education and socioeconomic status but most relevant, the spontaneous PTB prevalence was 17.9% for those excluded in the regression compared with 13.8% included in the regression.

Supplementary data

bmjopen-2022-066934supp001.pdf (84KB, pdf)

We also reran the regression model including number of ANC visits. The fewer the number of ANC visits, the higher the risk of spontaneous PTB (online supplemental table 2). The other regression coefficients did not change in any qualitative way. This could be due to fewer ANC visits putting women at higher risk of spontaneous PTB as services provided in ANC (counselling, iron folic acid tablets, BP and weight measurements) are provided less often, but this association may also be due to shorter duration of pregnancy leading to less time available for ANC visits.

Discussion

Our study is one of the only large-scale studies on PTBs using data from an existing pregnancy surveillance in rural Sarlahi, Nepal. The prevalence of PTB is 15%, higher than previous estimates from Nepal,18 19 which were primarily from urban areas and large hospital-based studies. Our study’s strength is that it was population based and included all home and facility deliveries but is confined to a rural and relatively small geographical area (one-third of a district). Our study population is not necessarily representative of all of Nepal, but it is representative of Province 2 in the Terai region within which Sarlahi district is located. For example, the NMR in our study was 31 per 1000 LBs. This is similar to the NMR in the 2016 Nepal Demographic Health Survey (NDHS) for Province 2 (30 per 1000). Similarly, 67% of women in our study had no schooling, slightly higher than the 61% in the NDHS for Province 2. NDHS did not provide data on ANC 4+ for Province 2 but rural areas of Nepal had 62% coverage of ANC 4+. It should be noted in our study that healthcare seeking in pregnancy is low considering the low rates of four or more ANC visits (28%) and facility deliveries (38%). The low rates of induction and caesarean section point to a very low proportion of the PTBs being due to iatrogenic causes.

In many other settings, both younger and older maternal age have been reported to be risk factors for PTB.24–30 Being from Muslim caste was positively associated with preterm as compared with Brahmin/Chhetri, which constitutes the major caste in Nepal. Caste/religion is a social construction, and studies in different places have shown that women in minor caste/race/colour have higher risk of PTBs.31–33 It significantly matters what position an individual holds within a society, with regard to occurrence of diseases and also their unequal distribution.34–36 First pregnancy (primipara) has been shown to be associated with spontaneous PTB in other studies. A study in France showed that primipara as compared with parity 2–3 increased the risk of PTB by 1.8 times.37 Another study in the USA showed that being primipara as compared with multipara increased the risk of very preterm and extremely PTB, with the highest risk of 1.37 times for extremely PTB.38 Meta-analysis done using 14 cohort studies from low/middle-income countries (LMICs)39 and a study from sub-Saharan African countries40 also show that primiparity is associated with increased odds of PTB. Primipara is a risk factor for hypertensive disorders of pregnancy, which increases the risk of PTB.41 Our study did not show IPI to be the risk factor for spontaneous PTB. However, other studies on relationships between IPI and PTB consistently showed that shorter IPIs increase the risk of PTBs. However, the intervals used were not uniform across studies. One study found that, compared with an IPI of 18–23 months, IPIs <3, 3–5 and 6–12 months had higher risks of PTB.42 Another study with median IPI of 36 months showed that, compared with an IPI of 24–36 months, an IPI of <24 months was associated with preterm delivery.43 Different studies corroborate our finding that multiple births are a risk factor for PTB.18 44 45 Similar to our study, others also found male children at higher risk of being preterm,46–48 but a study in Nepal found that female children had a higher risk of being preterm.18 This study in Nepal enrolled LBs in a hospital setting, and had almost half the prevalence of our study.18 They could have missed more boys that had PTBs at home or on the way to a facility.

Different studies in Nepal18 and outside of Nepal49–51 have also shown that higher education of mothers decreases the risk of PTBs. Higher education of mothers can lead to increased knowledge and awareness regarding pregnancy-related care and thus decrease adverse outcomes of pregnancy. We found greater maternal height to be protective for spontaneous PTB, similar to the findings from a meta-analysis done using 12 cohort studies from LMICs.52 We found that women in the richer wealth quintile had a lower risk of spontaneous PTBs. Having higher household economic status probably does not directly affect the GA at outcome, instead, it probably is mediated by factors like nutrition, physically demanding work during pregnancy, type of care at home, stress level and other psychological factors.53

Pregnancy-varying morbidities that significantly decreased the risk of PTB in our analysis were respiratory problems in the third trimester, and poor appetite, nausea and vomiting in the second trimester and the third trimester. On segregating the symptoms within respiratory problems, we found that it was the persistent cough in the third trimester that decreased the risk of PTB. A similar relationship was found between persistent cough and large for GA in another study done using the same data as ours.54 However, we could not find any such association in the previous literature. The association might be due to some unmeasured confounders, or it could be that women with persistent cough in the third trimester made more frequent check-up visits. We saw that 40% of women with persistent cough in the third trimester sought treatment for cough, and almost all had sought treatment more than once. The pathogenesis of nausea and vomiting in pregnancy is not very clear, but it is broadly accepted to be multifactorial, with the involvement of genetic, endocrine and GI factors.55 Our findings corroborate with previous findings that nausea and vomiting is associated with reduced risk of PTB.56–59 Specifying by trimesters, a study by Wallin et al in Nepal showed similar findings—poor appetite, nausea and vomiting in the first trimester were not significantly associated with spontaneous PTBs, but having these symptoms in the second trimester decreased the risk of spontaneous PTB by 25%.60

Pregnancy-varying morbidities that significantly increased the risk of spontaneous PTB were vaginal bleeding, swelling of hands and face, high diastolic and systolic BP, all in the third trimester. Vaginal bleeding is associated with fetal exposure to oral pathogens, which thereby increases the risk of spontaneous PTB; however, whether bleeding is the cause or result of fetal exposure to oral pathogens is not clear.61 A prospective cohort study, separating first and second trimesters, showed that vaginal bleeding in both trimesters increased the risk of PTB by 3.6 times, while bleeding in the second trimester only, was not associated with PTB.62 A systematic review using 23 studies showed that bleeding in early pregnancy increased the risk of PTBs.63 A study in China showed that vaginal bleeding in the first trimester increased the risk of PTBs, and the severity, duration and initial timing of vaginal bleeding had different effects on the severity of PTBs.61 Due to the low enrolment of women in the first trimester, we could not look at the association of vaginal bleeding in the first trimester with spontaneous PTB. However, all of the above information indicates that vaginal bleeding can be an important predictor of spontaneous PTB and healthcare workers should recommend appropriate interventions for women if they present with vaginal bleeding (such as more frequent follow-up or referral for higher level care).

Other studies on BP during pregnancy have also shown that a rise in systolic BP (over 30 mm Hg) or diastolic BP (over 15 mm Hg), from early pregnancy to the mid-third trimester, significantly increased the risk of spontaneous PTB by two to three times.64 Another study showed that an increase in 10 mm Hg in diastolic BP increased the risk of PTB by 29%.65 These indicate the importance of measuring BP during the third trimester. High BP in the third trimester is an indicator of pre-eclampsia/eclampsia and can predict PTB. Measuring BP frequently and monitoring the rise and cause of increased BP are important for predicting spontaneous PTB.

For maternal weight, higher weight gain from the second to the third trimester decreased the risk of spontaneous PTB. This is consistent with a study done outside Nepal, which showed that very low weight gain was strongly associated with very preterm delivery, and that this varied by pre-pregnancy body mass index (BMI), where underweight women had the highest association and very obese women had lowest association with PTB.66 Our study was conducted is a non-obese and undernourished population. We do not have pre-pregnancy BMI, so we looked at the mean BMI in the first trimester. Though the first trimester represents less half of the pregnancies in the study, it hints at undernutrition in the population. The mean BMI was 19.1 kg/m2, and 37% had BMI less than 18.5 kg/m2. So, less maternal weight gain in such population can pose a risk to spontaneous PTBs. Given spontaneous PTBs have shorter gestation, the increase in weight gain will likely be less because there is less time to increase weight, especially in the third trimester, when much of the gestational weight is gained.

Strengths and limitations

This was a large population-based study that was generally representative of the rural Terai region of Nepal. Multiple variables were collected, including socioeconomic, demographic, pregnancy history and monthly morbidity in pregnancy that could be examined as risk factors for spontaneous PTB. Although there were some missing data in regression analyses, a comparison of those with and without missing data did not show large differences in risk factor prevalence. However, those missing data had higher prevalence of PTB. It is possible that if women with missing data were included in the regression, we may have seen stronger associations but the potential bias of these differences is unclear. GA at birth was measured using date of LMP as usually done in the LMICs rather than by ultrasound. However, as LMP was asked at enrolment, which was generally early in pregnancy, there is less recall bias than LMP recalled at delivery or late in pregnancy. Using the same method as we used to obtain LMP, Gernand et al found that LMP-based estimates of GA in rural Bangladesh were a mean 2.8 days longer than what was obtained on ultrasound.67 We therefore believe that this is probably not a significant limitation. Women were followed prospectively at monthly intervals to reduce recall bias about pregnancy morbidities and symptoms. In order to reduce misclassification of SBs and LBs, women were asked whether the infant moved, breathed or cried after birth.

Some variables associated with increased risk of spontaneous PTBs in previous studies, for example, a prior pregnancy ending in a PTB, gestational diabetes, maternal anaemia and pre-pregnancy maternal nutritional status were not measured in the main trial. However, other important morbidity variables were measured and used in the analysis. Some covariates were highly correlated with each other (such as some reproductive history ones) and so, not all were included in the multivariable regression. Some covariates were not statistically significant in unadjusted analyses and there was not a compelling biological or sociological reason to include them in the adjusted model. Other important variables like smoking and alcohol, although measured, could not be included in the final regression analysis as their prevalence was very low in this population. We believe these risk factors are likely generalisable for similar populations in South Asia.

Conclusion

PTB is a leading risk factor for neonatal and under-5 mortality and morbidity worldwide. To reduce neonatal mortality, preventing PTBs can be a vital step. Some of the risk factors from our study are amenable to antenatal interventions but many others need more understanding of the underlying causal mechanisms. Maternal education and awareness can play a role in the long term, while good-quality ANC, as suggested by the new WHO recommendation of eight contacts during pregnancy, may help reduce some PTBs. Future research should focus on basic research involving the field of ‘omics’ using biological samples and implementation research to improve ANC and maternal nutrition.

Supplementary Material

Reviewer comments
Author's manuscript

Acknowledgments

We would like to acknowledge study staff and all participants at Nepal Nutritional Intervention Project—Sarlahi site. We would also like to give special thanks to Dr Leah Horton at Johns Hopkins Bloomberg School of Public Health for her technical contributions during data management.

Footnotes

Contributors: SS, EAH, DM, SZ, REB and JK conceptualised and designed the analysis. SS conducted the analysis and wrote the manuscript. LCM, JMT, SKK, SCL and JK were investigators in the parent trial. All authors reviewed results and analysis, discussed interpretations, and contributed to development and revision of the manuscript. SS is the guarantor and accepts full responsibility for the work and/or the conduct of the study, had access to the data, and controlled the decision to publish.

Funding: NOMS was supported by the National Institutes for Child Health and Development (HD060712) and the Bill & Melinda Gates Foundation (OPP1084399). The analysis for this paper was funded by the National Institutes for Child Health and Development (HD092411).

Disclaimer: The funders did not have a role in the design of the study, the data collection, nor the analysis, interpretation and writing of the manuscript.

Competing interests: None declared.

Patient and public involvement: Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.

Provenance and peer review: Not commissioned; externally peer reviewed.

Supplemental material: This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.

Data availability statement

No data are available.

Ethics statements

Patient consent for publication

Obtained.

Ethics approval

NOMS was approved by the Institutional Review Board (IRB) of the Johns Hopkins Bloomberg School of Public Health in the USA and by the IRB of the Institute of Medicine, Tribhuvan University, Kathmandu, Nepal. This analysis of secondary data was considered exempt by the Johns Hopkins Bloomberg School of Public Health IRB (FWA00000287). Verbal consent was obtained from women for their participation and their infants for the primary data collection.

References

  • 1.Dbstet A. WHO: recommended definitions, terminology and format for statistical tables related to the perinatal period and use of a new certificate for cause of perinatal deaths. modifications recommended by FIGO as amended October 14, 1976. Acta Obstet Gynecol Scand 1977;56:247–53. [PubMed] [Google Scholar]
  • 2.Blencowe H, Cousens S, Oestergaard MZ, et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet 2012;379:2162–72. 10.1016/S0140-6736(12)60820-4 [DOI] [PubMed] [Google Scholar]
  • 3.Perin J, Mulick A, Yeung D, et al. Global, regional, and national causes of under-5 mortality in 2000-19: an updated systematic analysis with implications for the sustainable development goals. Lancet Child Adolesc Health 2022;6:106–15. 10.1016/S2352-4642(21)00311-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Chawanpaiboon S, Vogel JP, Moller A-B, et al. Global, regional, and national estimates of levels of preterm birth in 2014: a systematic review and modelling analysis. Lancet Glob Health 2019;7:e37–46. 10.1016/S2214-109X(18)30451-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Araújo BFde, Zatti H, Madi JM, et al. Analysis of neonatal morbidity and mortality in late-preterm newborn infants. J Pediatr 2012;88:259–66. 10.2223/jped.2196 [DOI] [PubMed] [Google Scholar]
  • 6.Mwaniki MK, Atieno M, Lawn JE, et al. Long-term neurodevelopmental outcomes after intrauterine and neonatal insults: a systematic review. Lancet 2012;379:445–52. 10.1016/S0140-6736(11)61577-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Vogel JP, Chawanpaiboon S, Moller A-B, et al. The global epidemiology of preterm birth. Best Pract Res Clin Obstet Gynaecol 2018;52:1e10:3–12. 10.1016/j.bpobgyn.2018.04.003 [DOI] [PubMed] [Google Scholar]
  • 8.Orchinik LJ, Taylor HG, Espy KA, et al. Cognitive outcomes for extremely preterm/extremely low birth weight children in kindergarten. J Int Neuropsychol Soc 2011;17:1067–79. 10.1017/S135561771100107X [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Johnson S, Evans TA, Draper ES, et al. Neurodevelopmental outcomes following late and moderate prematurity: a population-based cohort study. Arch Dis Child Fetal Neonatal Ed 2015;100:F301–8. 10.1136/archdischild-2014-307684 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Moreira RS, Magalhães LC, Alves CRL. Effect of preterm birth on motor development, behavior, and school performance of school-age children: a systematic review. J Pediatr 2014;90:119–34. 10.1016/j.jped.2013.05.010 [DOI] [PubMed] [Google Scholar]
  • 11.Petrou S, Abangma G, Johnson S, et al. Costs and health utilities associated with extremely preterm birth: evidence from the EPICure study. Value Health 2009;12:1124–34. 10.1111/j.1524-4733.2009.00580.x [DOI] [PubMed] [Google Scholar]
  • 12.Singer LT, Salvator A, Guo S, et al. Maternal psychological distress and parenting stress after the birth of a very low-birth-weight infant. JAMA 1999;281:799–805. 10.1001/jama.281.9.799 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Family Health Division of the Department of Health Services of the Ministry of Health/Nepal, New ERA/Nepal, Macro O . Nepal demographic and health survey 2001, 2002. [Google Scholar]
  • 14.Ministry of Health - MOH/Nepal, New ERA/Nepal, ICF . Nepal demographic and health survey 2016, 2017. [Google Scholar]
  • 15.Ministry of Health and Population - MOHP/Nepal, New ERA/Nepal, International M . Nepal demographic and health survey 2006, 2007. [Google Scholar]
  • 16.Vogel JP, Chawanpaiboon S, Moller A-B, et al. The global epidemiology of preterm birth. Best Pract Res Clin Obstet Gynaecol 2018;52:3–12. 10.1016/j.bpobgyn.2018.04.003 [DOI] [PubMed] [Google Scholar]
  • 17.National Planning Commission . Sustainable development goals 2016–2030: national (preliminary) report. Kathmandu: National Planning Commission, 2015. [Google Scholar]
  • 18.Gurung A, Wrammert J, Sunny AK, et al. Incidence, risk factors and consequences of preterm birth – findings from a multi-centric observational study for 14 months in Nepal. Arch Public Health 2020;78:1–9. 10.1186/s13690-020-00446-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Ashish KC, Wrammert J, Nelin V. Level of mortality risk for babies born preterm or with a small weight for gestation in a tertiary hospital of Nepal. BMC Public Health 2015;15:1–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Anonymous . Nepal: share of rural population 2021.
  • 21.Bryce E, Gurung S, Tong H, et al. Population attributable fractions for risk factors for spontaneous preterm births in 81 low- and middle-income countries: a systematic analysis. J Glob Health 2022;12:04013. 10.7189/jogh.12.04013 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Dahal DR. Social composition of the population: caste/ethnicity and religion in Nepal. Population Monograph of Nepal 2003;1:87–135. [Google Scholar]
  • 23.Rutstein SO, Johnson K. The DHS wealth index. DHS comparative reports no. 6. Calverton: ORC Macro, 2004. [Google Scholar]
  • 24.Wagura P, Wasunna A, Laving A, et al. Prevalence and factors associated with preterm birth at kenyatta national Hospital. BMC Pregn Child 2018;18:1–8. 10.1186/s12884-018-1740-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Fuchs F, Monet B, Ducruet T, et al. Effect of maternal age on the risk of preterm birth: a large cohort study. PLoS One 2018;13:e0191002. 10.1371/journal.pone.0191002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Weng Y-H, Yang C-Y, Chiu Y-W. Risk assessment of adverse birth outcomes in relation to maternal age. PLoS One 2014;9:e114843. 10.1371/journal.pone.0114843 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Muhihi A, Sudfeld CR, Smith ER, et al. Risk factors for small-for-gestational-age and preterm births among 19,269 Tanzanian newborns. BMC Pregnancy Childbirth 2016;16:1–12. 10.1186/s12884-016-0900-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Anderson C, Smitherman AB, Engel SM, et al. Modifiable and non-modifiable risk factors for preterm delivery among adolescent and young adult cancer survivors. Cancer Causes Control 2018;29:289–95. 10.1007/s10552-017-0992-x [DOI] [PubMed] [Google Scholar]
  • 29.Leonard SA, Crespi CM, Gee DC, et al. Prepregnancy risk factors for preterm birth and the role of maternal nativity in a low-income, Hispanic population. Matern Child Health J 2015;19:2295–302. 10.1007/s10995-015-1748-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Kildea SV, Gao Y, Rolfe M, et al. Risk factors for preterm, low birthweight and small for gestational age births among Aboriginal women from remote communities in northern Australia. Women Birth 2017;30:398–405. 10.1016/j.wombi.2017.03.003 [DOI] [PubMed] [Google Scholar]
  • 31.Menon R, Dunlop AL, Kramer MR, et al. An overview of racial disparities in preterm birth rates: caused by infection or inflammatory response? Acta Obstet Gynecol Scand 2011;90:1325–31. 10.1111/j.1600-0412.2011.01135.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Kramer MR, Hogue CJ, Dunlop AL, et al. Preconceptional stress and racial disparities in preterm birth: an overview. Acta Obstet Gynecol Scand 2011;90:1307–16. 10.1111/j.1600-0412.2011.01136.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Patel RR, Steer P, Doyle P, et al. Does gestation vary by ethnic group? A London-based study of over 122,000 pregnancies with spontaneous onset of labour. Int J Epidemiol 2004;33:107–13. 10.1093/ije/dyg238 [DOI] [PubMed] [Google Scholar]
  • 34.Goodman AH. Why genes don't count (for racial differences in health). Am J Public Health 2000;90:1699. 10.2105/ajph.90.11.1699 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Krieger N. A glossary for social epidemiology. J Epidemiol Community Health 2001;55:693–700. 10.1136/jech.55.10.693 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Wilkinson RG, Marmot M. Social determinants of health: the solid facts. World Health Organization, 2003. [Google Scholar]
  • 37.Delnord M, Blondel B, Prunet C, et al. Are risk factors for preterm and early-term live singleton birth the same? A population-based study in France. BMJ Open 2018;8:e018745. 10.1136/bmjopen-2017-018745 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Salihu H, Mbah AK, Alio AP, et al. Nulliparity and preterm birth in the era of obesity epidemic. J Matern Fetal Neonatal Med 2010;23:1444–50. 10.3109/14767051003678044 [DOI] [PubMed] [Google Scholar]
  • 39.Kozuki N, Lee ACC, Silveira MF, et al. The associations of parity and maternal age with small-for-gestational-age, preterm, and neonatal and infant mortality: a meta-analysis. BMC Public Health 2013;13:1–10. 10.1186/1471-2458-13-S3-S2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Alamneh TS, Teshale AB, Worku MG, et al. Preterm birth and its associated factors among reproductive aged women in sub-Saharan Africa: evidence from the recent demographic and health surveys of sub-Sharan African countries. BMC Pregnancy Childbirth 2021;21:1–11. 10.1186/s12884-021-04233-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Ye C, Ruan Y, Zou L, et al. The 2011 survey on hypertensive disorders of pregnancy (HDP) in China: prevalence, risk factors, complications, pregnancy and perinatal outcomes. PLoS One 2014;9:e100180. 10.1371/journal.pone.0100180 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Nerlander LM, Callaghan WM, Smith RA, et al. Short interpregnancy interval associated with preterm birth in U S adolescents. Matern Child Health J 2015;19:850–8. 10.1007/s10995-014-1583-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Mahande MJ, Obure J. Effect of interpregnancy interval on adverse pregnancy outcomes in northern Tanzania: a registry-based retrospective cohort study. BMC Pregnancy Childbirth 2016;16:1–9. 10.1186/s12884-016-0929-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Kim JI, Cho MO, Choi GY. [Multiple factors in the second trimester of pregnancy on preterm labor symptoms and preterm birth]. J Korean Acad Nurs 2017;47:357–66. 10.4040/jkan.2017.47.3.357 [DOI] [PubMed] [Google Scholar]
  • 45.Shah R, Mullany LC, Darmstadt GL. Incidence and risk factors of preterm birth in a rural Bangladeshi cohort. BMC Pediatr 2014;14:1–11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Peelen MJCS, Kazemier BM, Ravelli ACJ, et al. Impact of fetal gender on the risk of preterm birth, a national cohort study. Acta Obstet Gynecol Scand 2016;95:1034–41. 10.1111/aogs.12929 [DOI] [PubMed] [Google Scholar]
  • 47.Zeitlin J, Ancel P-Y, Larroque B, et al. Fetal sex and indicated very preterm birth: results of the EPIPAGE study. Am J Obstet Gynecol 2004;190:1322–5. 10.1016/j.ajog.2003.10.703 [DOI] [PubMed] [Google Scholar]
  • 48.Lao TT, Sahota DS, Suen SSH, et al. The impact of fetal gender on preterm birth in a southern Chinese population. J Matern Fetal Neonatal Med 2011;24:1440–3. 10.3109/14767058.2011.589872 [DOI] [PubMed] [Google Scholar]
  • 49.Poulsen G, Strandberg-Larsen K, Mortensen L, et al. Exploring educational disparities in risk of preterm delivery: a comparative study of 12 European birth cohorts. Paediatr Perinat Epidemiol 2015;29:172–83. 10.1111/ppe.12185 [DOI] [PubMed] [Google Scholar]
  • 50.Oftedal A-M, Busterud K, Irgens LM, et al. Socio-economic risk factors for preterm birth in Norway 1999-2009. Scand J Public Health 2016;44:587–92. 10.1177/1403494816653288 [DOI] [PubMed] [Google Scholar]
  • 51.Auger N, Leduc L, Naimi AI, et al. Delivery at term: impact of university education by week of gestation. J Obstet Gynaecol Can 2016;38:118–24. 10.1016/j.jogc.2015.11.001 [DOI] [PubMed] [Google Scholar]
  • 52.Kozuki N, Katz J, Lee ACC, et al. Short maternal stature increases risk of small-for-gestational-age and preterm births in low- and middle-income countries: individual participant data meta-analysis and population attributable fraction. J Nutr 2015;145:2542–50. 10.3945/jn.115.216374 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Kramer MS, Goulet L, Lydon J, et al. Socioeconomic disparities in preterm birth: causal pathways and mechanisms. Paediatr Perinat Epidemiol 2001;15:104–23. 10.1046/j.1365-3016.2001.00012.x [DOI] [PubMed] [Google Scholar]
  • 54.Hazel EA, Mohan D, Zeger S. Demographic, socio-economic, obstetric, and behavioral factors associated with small-and large-for-gestational-age from a prospective, population-based pregnancy cohort in rural Nepal: a secondary data analysis. BMC Pregnancy and Childbirth 2022;22:1–13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Bustos M, Venkataramanan R, Caritis S. Nausea and vomiting of pregnancy - What's new? Auton Neurosci 2017;202:62–72. 10.1016/j.autneu.2016.05.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Tierson FD, Olsen CL, Hook EB. Nausea and vomiting of pregnancy and association with pregnancy outcome. Am J Obstet Gynecol 1986;155:1017–22. 10.1016/0002-9378(86)90337-6 [DOI] [PubMed] [Google Scholar]
  • 57.Petitti DB. Nausea and pregnancy outcome. Birth 1986;13:223–6. 10.1111/j.1523-536x.1986.tb01052.x [DOI] [PubMed] [Google Scholar]
  • 58.Koren G, Clark S, Hankins GDV, et al. Maternal safety of the delayed-release doxylamine and pyridoxine combination for nausea and vomiting of pregnancy; a randomized placebo controlled trial. BMC Pregnancy Childbirth 2015;15:1–6. 10.1186/s12884-015-0488-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Klebanoff MA, Koslowe PA, Kaslow R, et al. Epidemiology of vomiting in early pregnancy. Obstet Gynecol 1985;66:612–6. [PubMed] [Google Scholar]
  • 60.Wallin AR, Tielsch JM, Khatry SK. Nausea, vomiting and poor appetite during pregnancy and adverse birth outcomes in rural Nepal: an observational cohort study. BMC Pregnancy Childbirth 2020;20:1–12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Boggess KA, Moss K, Murtha A, et al. Antepartum vaginal bleeding, fetal exposure to oral pathogens, and risk for preterm birth at <35 weeks of gestation. Am J Obstet Gynecol 2006;194:954–60. 10.1016/j.ajog.2006.02.026 [DOI] [PubMed] [Google Scholar]
  • 62.Yang J, Hartmann KE, Savitz DA, et al. Vaginal bleeding during pregnancy and preterm birth. Am J Epidemiol 2004;160:118–25. 10.1093/aje/kwh180 [DOI] [PubMed] [Google Scholar]
  • 63.Hackney DN, Glantz JC. Vaginal bleeding in early pregnancy and preterm birth: systemic review and analysis of heterogeneity. J Matern Fetal Neonatal Med 2011;24:778–86. 10.3109/14767058.2010.530707 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Zhang J, Villar J, Sun W, et al. Blood pressure dynamics during pregnancy and spontaneous preterm birth. Am J Obstet Gynecol 2007;197:162.e1–162.e6. 10.1016/j.ajog.2007.03.053 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Chatzi L, Plana E, Daraki V, et al. Metabolic syndrome in early pregnancy and risk of preterm birth. Am J Epidemiol 2009;170:829–36. 10.1093/aje/kwp211 [DOI] [PubMed] [Google Scholar]
  • 66.Dietz PM, Callaghan WM, Cogswell ME, et al. Combined effects of prepregnancy body mass index and weight gain during pregnancy on the risk of preterm delivery. Epidemiology 2006;17:170–7. 10.1097/01.ede.0000198470.26932.9a [DOI] [PubMed] [Google Scholar]
  • 67.Gernand AD, Paul RR, Ullah B, et al. A home calendar and recall method of last menstrual period for estimating gestational age in rural Bangladesh: a validation study. J Health Popul Nutr 2016;35:1–9. 10.1186/s41043-016-0072-y [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary data

bmjopen-2022-066934supp001.pdf (84KB, pdf)

Reviewer comments
Author's manuscript

Data Availability Statement

No data are available.


Articles from BMJ Open are provided here courtesy of BMJ Publishing Group

RESOURCES